Werewolf Therapeutics announced it will deliver an oral presentation and two posters at the Society for Immunotherapy of Cancer’s 2026 Annual Meeting in November. The presentations will cover clinical studies of their tumor-activated IL-2 and IL-12 prodrugs, WTX-124 and WTX-330, aimed at treating advanced solid tumors by stimulating the immune system. This exposure highlights Werewolf's progress in developing innovative cancer immunotherapies that activate selectively within tumors. Investors may watch for clinical data updates that could impact the company’s development pipeline and valuation.
Werewolf Therapeutics' upcoming presentations at the Society for Immunotherapy of Cancer’s 2026 Annual Meeting provide context for the health sector's market activity on Pluang as of Oct 30, 2026 18:43 WIB. Of 150 priced health-sector US stocks, 71 rose and 72 fell today. Illumina (ILMN) dropped 12.95% with a typical hold time of 84 days and 100% sell orders, contrasting with Inovio Pharmaceuticals (INO) which gained 11.43% with a shorter hold time of 43 days and 28% buy orders. Meanwhile, Stryker Corporation (SYK) fell 11.03% but saw 100% buy orders and a typical hold time of 21 days.
FreightCar America disclosed on October 19, 2026, that it removed 1,285 railcars from its backlog after a customer was unlikely to fulfill contractual obligations, causing its stock to drop 31.4% to $4.02. This sharp decline has led Glancy Prongay Wo...
FirstCash Holdings, Inc. shares fell 14.75% following the October 22, 2026 disclosure of its third quarter financial results, which showed a 28% year-over-year decline in operating income for its American First Finance segment to $33 million. The com...
The global screw compressors market is projected to grow from $13.97 billion in 2026 to $18.38 billion by 2031, at a CAGR of 5.66%. Growth is fueled by rising industrial automation, energy-efficiency regulations, and demand in manufacturing, oil and ...
Enova International's stock fell 23.43% after the company withdrew its application to acquire Grasshopper Bancorp and become a bank holding company. The withdrawal was due to unclear regulatory standards and political pressures cited by Enova. This s...
The global dialysis machines market is forecasted to grow from $17.89 billion in 2026 to $31.54 billion by 2035, at a CAGR of 6.5%. Growth is fueled by rising chronic kidney disease cases, expanding dialysis infrastructure, and innovations like home ...
